Jim Cramer explains why he's letting this pharma stock run rather than taking profits

This is one of those times when there's a stock in the portfolio that tests our discipline and conviction. It's understandable that some investors may want to trim this stock, but Jim thinks this pharma company will deliver the best-selling drug of all time and is sticking with it.